Can DNA-Guided dosing reduce drug risks for african americans?

NCT ID NCT03225820

Recruiting now Knowledge-focused Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 23 times

Summary

This study looks at whether giving doctors genetic information about their African American patients can help them prescribe medications more safely, especially the blood thinner warfarin. Researchers will track how often doctors use this genetic guidance and whether it leads to better health outcomes. About 1,000 African American adults will take part across multiple hospitals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFORMATION SEEKING BEHAVIOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Northwestern University
NOT_YET_RECRUITING

Chicago, Illinois, 60611, United States

Contact Phone: •••-•••-••••
The University of Illinois at Chicago
RECRUITING

Chicago, Illinois, 60607, United States

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

INFORMATION SEEKING BEHAVIOR